253 related articles for article (PubMed ID: 33128074)
1. Methotrexate osteopathy: five cases and systematic literature review.
Robin F; Cadiou S; Albert JD; Bart G; Coiffier G; Guggenbuhl P
Osteoporos Int; 2021 Feb; 32(2):225-232. PubMed ID: 33128074
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of methotrexate osteopathy in rheumatic musculoskeletal disease: A systematic review.
Ruffer N; Krusche M; Beil FT; Amling M; Kötter I; Rolvien T
Semin Arthritis Rheum; 2022 Feb; 52():151952. PubMed ID: 35038641
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate osteopathy, does it exist?
Maenaut K; Westhovens R; Dequeker J
J Rheumatol; 1996 Dec; 23(12):2156-9. PubMed ID: 8970056
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis.
Zonneveld IM; Bakker WK; Dijkstra PF; Bos JD; van Soesbergen RM; Dinant HJ
Arch Dermatol; 1996 Feb; 132(2):184-7. PubMed ID: 8629827
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Radiological Characterization of Patients with Immobilizing and Progressive Stress Fractures in Methotrexate Osteopathy.
Rolvien T; Jandl NM; Stürznickel J; Beil FT; Kötter I; Oheim R; Lohse AW; Barvencik F; Amling M
Calcif Tissue Int; 2021 Feb; 108(2):219-230. PubMed ID: 33064170
[TBL] [Abstract][Full Text] [Related]
6. The effect of low dose methotrexate on bone density.
Cranney AB; McKendry RJ; Wells GA; Ooi DS; Kanigsberg ND; Kraag GR; Smith CD
J Rheumatol; 2001 Nov; 28(11):2395-9. PubMed ID: 11708409
[TBL] [Abstract][Full Text] [Related]
7. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis.
Buckley LM; Leib ES; Cartularo KS; Vacek PM; Cooper SM
J Rheumatol; 1997 Aug; 24(8):1489-94. PubMed ID: 9263140
[TBL] [Abstract][Full Text] [Related]
8. Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study.
di Munno O; Mazzantini M; Sinigaglia L; Bianchi G; Minisola G; Muratore M; la Corte R; di Matteo L; Canesi B; Caminiti M; Broggini M; Adami S
J Rheumatol; 2004 Jul; 31(7):1305-9. PubMed ID: 15229948
[TBL] [Abstract][Full Text] [Related]
9. [Three patients with a fracture during methotrexate use, possibly due to methotrexate osteopathy].
van der Bijl AE; Zijlstra TR; Engelage AH; Posthuma BJ; van Veen GJ
Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2357-60. PubMed ID: 19024069
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density.
Minaur NJ; Kounali D; Vedi S; Compston JE; Beresford JN; Bhalla AK
Rheumatology (Oxford); 2002 Jul; 41(7):741-9. PubMed ID: 12096222
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis in rheumatoid arthritis.
Dequeker J; Maenaut K; Verwilghen J; Westhovens R
Clin Exp Rheumatol; 1995; 13 Suppl 12():S21-6. PubMed ID: 8846540
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate osteopathy demonstrated by Technetium-99m HDP bone scintigraphy.
Stevens H; Jacobs JW; Van Rijk PP; De Klerk JM
Clin Nucl Med; 2001 May; 26(5):389-91. PubMed ID: 11317015
[TBL] [Abstract][Full Text] [Related]
13. [The effect of low dose methotrexate treatment on bone mineral density in patients with rheumatoid arthritis].
Kita K; Sierakowski S
Pol Merkur Lekarski; 2002 Feb; 12(68):122-5. PubMed ID: 11995248
[TBL] [Abstract][Full Text] [Related]
14. Stress fractures in systemic lupus erythematosus after long-term MTX use successfully treated by MTX discontinuation and individualized bone-specific therapy.
Rolvien T; Creutzfeldt AM; Lohse AW; Amling M
Lupus; 2019 May; 28(6):790-793. PubMed ID: 30947618
[TBL] [Abstract][Full Text] [Related]
15. [Drug-induced osteopathy in rheumatology].
Fiehn C; Bauhammer J
Z Rheumatol; 2022 Apr; 81(3):189-197. PubMed ID: 35006380
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate in the treatment of rheumatoid arthritis. I. In vitro effects on cells of the osteoblast lineage.
Minaur NJ; Jefferiss C; Bhalla AK; Beresford JN
Rheumatology (Oxford); 2002 Jul; 41(7):735-40. PubMed ID: 12096221
[TBL] [Abstract][Full Text] [Related]
17. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review.
Kremer JM; Alarcón GS; Weinblatt ME; Kaymakcian MV; Macaluso M; Cannon GW; Palmer WR; Sundy JS; St Clair EW; Alexander RW; Smith GJ; Axiotis CA
Arthritis Rheum; 1997 Oct; 40(10):1829-37. PubMed ID: 9336418
[TBL] [Abstract][Full Text] [Related]
18. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
[TBL] [Abstract][Full Text] [Related]
19. Rheumatoid arthritis and osteoporosis.
Westhovens R; Dequeker J
Z Rheumatol; 2000; 59 Suppl 1():33-8. PubMed ID: 10769433
[TBL] [Abstract][Full Text] [Related]
20. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
Nash P; Nicholls D
Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]